Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T16:41:32.676Z.
Calculation as of: 2026-10-06T16:41:32.676Z.
Quote observation: 2026-10-06T16:40:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3557795f844472894604fcbd35c20595803ff4fe2165ab850e9e673e91650e7f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Market Cap
$30.69M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BeyondSpring Inc. (BYSI) | $29.96M | N/A | N/A | N/A | N/A |
| MDxHealth S.A. (MDXH)vs › | $29.99M | N/A | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.88M | N/A | N/A | N/A | N/A |
| OneMedNet Corporation (ONMD)vs › | $29.70M | N/A | 2.80 | 2.80 | 2.80 |
| CervoMed Inc. (CRVO)vs › | $30.23M | N/A | N/A | N/A | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.60M | N/A | N/A | N/A | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $29.41M | N/A | N/A | N/A | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.69M | N/A | N/A | N/A | N/A |
| SCYNEXIS, Inc. (SCYX)vs › | $30.94M | N/A | 4.37 | 4.37 | 4.37 |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 10.25 | 11.37 | 193.26 | 145.59 |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
